Sign inJoin waitlistJoin the waitlist

Adilia Hormigo

Director, Neuro-Oncology · Montefiore Medical Center/Albert Einstein College of Medicine

Credentials: · · · · ·

History

Memorial Sloan Kettering Cancer Center
2003–2004
New York Presbyterian Hospital
1999–2003
Lisbon Medical School
1977–1981

Research

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
Journal of Clinical Investigation · 2008 · 730 citations
Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice
Nature Medicine · 2010 · 279 citations
Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma
Journal of Clinical Oncology · 2006 · 241 citations

LD
Lisa DeAngelis
14 papers
Kambiz Nael
11 papers
LA
Lauren Abrey
10 papers
Nadejda Tsankova
10 papers
Andrew Lassman
7 papers
FI
Fabio Iwamoto
7 papers · 3 as a resident
SK
Sasan Karimi
7 papers
Antonio Omuro
5 papers
CN
Craig Nolan
5 papers
Igor Gavrilovic
5 papers
SK
Shingo Kihira
5 papers · 4 as a resident
Adam Bauer
4 papers

Grants

Mount Sinai Network of Excellence in Neuroscience Clinical Trials
National Institute of Neurological Disorders and Stroke · U24
PI · $1M · Icahn School of Medicine at Mount Sinai
2018–2023

Clinical trials

Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma
Principal investigator · Completed · Phase 1
Icahn School of Medicine at Mount Sinai
2018–2021
Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
Principal investigator · Active not recruiting · Phase 1
Adilia Hormigo
2018–2029